• 6 mins read
  • Published

Hinge Health Stock Surges as Cramer Sees More Upside After Q2 Results

Jane Quinn Personal finance author FinancialSumo

Post by Jane Quinn

Hinge Health Stock Surges as Cramer Sees More Upside After Q2 Results FinancialSumo © financialsumo.com
Hinge Health Stock Surges as Cramer Sees More Upside After Q2 Results © financialsumo.com

Hinge Health's shares have soared nearly 86% in 2026, but Jim Cramer argues the company's latest earnings and expansion moves could mean the rally is just getting started for this digital health stock

Hinge Health, a digital health company focused on musculoskeletal (MSK) care, has become one of the year's standout performers on Wall Street. The stock climbed to a record $93.13 on August 10, up 85.83% year to date, according to Yahoo Finance. Despite the rapid rise, Jim Cramer delivered a rare triple "buy" call on the August 11 episode of "Mad Money" Lightning Round, signaling his conviction that the company's growth story is far from over.

Founded in 2014 by Daniel Perez and Gabriel Mecklenburg, Hinge Health uses an artificial intelligence-powered platform to deliver personalized MSK care for chronic pain, injuries, and post-surgical rehabilitation. Unlike many digital health startups, Hinge Health targets large employers and health plans, offering digital physical therapy and care management to reduce costly medical claims. As of June 30, 2026, the company served 2,929 clients-up 24% from a year earlier-including more than half of the Fortune 100, according to its latest earnings release.

Financial Momentum

Hinge Health's second-quarter 2026 results underscored why the market is paying attention. Revenue jumped 53% year over year to $213 million, while non-GAAP operating income more than doubled to $61.5 million. The company's operating margin expanded to 29%, up from 19% in the same period last year. Free cash flow-a key measure of financial health-tripled to $99.6 million, representing a robust 47% margin. Management raised full-year revenue guidance to a range of $856 million to $860 million, which would mark 46% growth at the midpoint. Non-GAAP operating income guidance was also increased, now expected to reach $236 million to $244 million for the year, or 101% growth.

Hinge Health's business model appears to be gaining traction with large employers seeking to manage rising healthcare costs. The company reported last twelve months (LTM) billings of $861.8 million, up 52% year over year. Its client roster now includes a significant share of major U.S. corporations, reflecting growing acceptance of digital MSK care as a cost-saving benefit.

Strategic Expansion

Beyond its core MSK offering, Hinge Health is moving quickly to broaden its platform. In April 2026, the company launched a Migraine Care Program, which has already signed up more than 450 clients and covers over 5 million lives. This rapid adoption suggests that existing enterprise customers are willing to expand their relationship with Hinge Health into new clinical areas.

On August 4, Hinge Health announced a $105 million acquisition of Cylinder Health, a move that extends its reach into gastrointestinal (GI) care. The deal brings nearly 100 enterprise clients, 2 million covered lives, and partnerships with two of the three largest pharmacy benefit managers. GI conditions are a major cost driver in U.S. healthcare, affecting about one in four adults and accounting for $135 billion in annual spending. The acquisition positions Hinge Health to address a significant access gap, as 69% of U.S. counties lack a gastroenterologist.

Share Buybacks and Market Confidence

In a further sign of confidence, Hinge Health's board approved a $300 million increase to its share repurchase program in late July, bringing total authorized buybacks to nearly $500 million. The company has already repurchased $196.5 million in shares. For a high-growth company with strong free cash flow, aggressive buybacks can help manage dilution and signal management's belief in the business's long-term prospects.

While Hinge Health's stock has already delivered substantial gains in 2026, Cramer's bullish stance reflects the company's accelerating financial performance and its push into new markets. Investors should note, however, that rapid growth and expansion come with execution risks, especially as the company integrates acquisitions and scales new product lines.

Broader Context

Hinge Health's approach-targeting employers and health plans rather than individual consumers-mirrors a broader trend in digital health, where companies seek to embed their services within the existing healthcare infrastructure. This strategy can offer more stable revenue streams but also requires navigating complex relationships with insurers, benefit managers, and large corporate clients. For those interested in how prominent investors like Jim Cramer think about portfolio construction and risk, his three-asset approach to retirement security offers additional perspective on balancing growth and stability in uncertain markets, as discussed in this analysis of Cramer's retirement strategy.

According to Hinge Health's Q2 2026 earnings report, the company's Migraine Care Program and Cylinder Health acquisition are expected to expand its total addressable market and deepen its relationships with large employers. The company's ability to deliver both rapid revenue growth and expanding margins sets it apart from many digital health peers, but investors should continue to monitor competitive pressures and the pace of adoption for new offerings.

For the second quarter of 2026, Hinge Health reported revenue of $213 million, non-GAAP operating income of $61.5 million, and free cash flow of $99.6 million. The company's client base grew to 2,929, and its last twelve months billings reached $861.8 million. These figures reflect both strong demand for digital MSK care and the company's success in expanding its platform to new clinical areas.

Digital health companies that focus on enterprise clients face a unique set of challenges and opportunities. While large contracts can provide predictable revenue and scale, they also require significant investment in technology, compliance, and customer support. The ability to cross-sell new services-such as migraine and GI care-depends on both clinical effectiveness and the willingness of employers to expand benefits. As the digital health sector matures, companies like Hinge Health will need to demonstrate not just growth, but sustainable profitability and operational discipline to maintain investor confidence.

Related articles